Sidoti Forecasts GoHealth’s Q1 Earnings (NASDAQ:GOCO)

GoHealth, Inc. (NASDAQ:GOCO) – Analysts at Sidoti increased their Q1 2026 EPS estimates for shares of GoHealth in a report issued on Thursday, April 2nd. Sidoti analyst J. Sidoti now anticipates that the company will post earnings of ($1.47) per share for the quarter, up from their previous estimate of ($1.71). The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Sidoti also issued estimates for GoHealth’s Q2 2026 earnings at ($1.50) EPS, Q3 2026 earnings at ($1.47) EPS, FY2026 earnings at ($6.23) EPS, Q1 2027 earnings at ($1.44) EPS, Q2 2027 earnings at ($1.61) EPS, Q3 2027 earnings at ($1.61) EPS, Q4 2027 earnings at ($1.09) EPS and FY2027 earnings at ($5.75) EPS.

Several other brokerages have also issued reports on GOCO. Noble Financial upgraded shares of GoHealth to a “strong-buy” rating in a research note on Wednesday, April 1st. Freedom Capital lowered shares of GoHealth from a “strong-buy” rating to a “hold” rating in a research note on Monday. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $5.00.

GoHealth Trading Down 7.9%

Shares of GOCO stock opened at $1.16 on Tuesday. GoHealth has a 1 year low of $1.12 and a 1 year high of $11.36. The firm’s fifty day moving average price is $1.69 and its two-hundred day moving average price is $2.71. The firm has a market capitalization of $33.30 million, a P/E ratio of -0.06 and a beta of 1.61.

GoHealth (NASDAQ:GOCO) last issued its quarterly earnings results on Tuesday, March 31st. The company reported ($1.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.69) by $1.66. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. The firm had revenue of $12.64 million for the quarter, compared to analyst estimates of $88.62 million.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Public Sector Pension Investment Board bought a new position in shares of GoHealth in the 3rd quarter valued at about $8,100,000. Corient Private Wealth LLC grew its position in shares of GoHealth by 7.7% in the 2nd quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock valued at $699,000 after acquiring an additional 8,979 shares during the period. Geode Capital Management LLC grew its position in shares of GoHealth by 8.1% in the 4th quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock valued at $324,000 after acquiring an additional 11,340 shares during the period. Empowered Funds LLC grew its position in shares of GoHealth by 7.7% in the 1st quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock valued at $307,000 after acquiring an additional 1,790 shares during the period. Finally, Focus Partners Wealth bought a new position in shares of GoHealth in the 3rd quarter valued at about $270,000. Institutional investors own 24.21% of the company’s stock.

More GoHealth News

Here are the key news stories impacting GoHealth this week:

• Positive Sentiment: Sidoti raised multiple near-term estimates and trimmed expected losses — the firm boosted Q1–Q3 2026 and several 2027 quarter forecasts and cut its Q3 2026 loss estimate sharply (from ($3.30) to ($1.47)), and also narrowed FY2026 and FY2027 losses, signaling improving margin expectations.
• Positive Sentiment: Noble Financial lifted its FY2027 EPS view materially to a positive $1.93 and retains a “Strong‑Buy” stance, implying at least one analyst expects a recovery into positive earnings by 2027.
• Neutral Sentiment: Sidoti published a full schedule of quarter-by-quarter EPS projections (Q1–Q4 2026/2027 and FY figures), providing updated modeling inputs for investors but not changing consensus direction on current-year losses.
• Negative Sentiment: Noble trimmed its FY2026 view to ($8.55) from ($7.53), increasing near-term expected losses and adding uncertainty to the recovery timeline.
• Negative Sentiment: Freedom Capital downgraded GoHealth from “Strong‑Buy” to “Hold,” a near-term negative for sentiment among retail/small institutional holders. Freedom Capital downgrade
• Negative Sentiment: Fundamentals remain weak: recent quarterly results showed a very large revenue shortfall and continued negative EPS and margins; market cap is small and the company sits near its 52‑week low, making the stock sensitive to analyst sentiment and liquidity.

About GoHealth

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.